Press "Enter" to skip to content

FDA Qualifies First Biomarker Test as Part of Medical Device Development Tools (MDDT) Program

The U.S. Food and Drug Administration (FDA) has qualified the OsiriX CDE Software Module through the Medical Device Development Tools (MDDT) program

Be First to Comment

Leave a Reply

Your email address will not be published.